COVID-19 Therapy Available

COVID Therapies Available for Outpatients at Cheyenne Regional Medical Center (CRMC) and Cheyenne Regional Medical Group (CRMG) Clinics

CRMC and CRMG  have several therapeutic options available for COVID treatment including antivirals and monoclonal antibody administration.

At CRMG Family and Internal Medicine Clinics, providers may prescribe and provide an oral antiviral therapy to eligible patients. Providers may also refer patients for a different antiviral therapy to be given by IV infusion at the CRMG Plaza (20th Street) location.

Eligibility requirements for antiviral medications differ significantly between available products. Please contact your primary care provider if you are interested in qualifying for an antiviral medication for COVID-19 infections.

Monoclonal antibody therapy is currently only available through the CRMC emergency department.

Who is NOT eligible for monoclonal antibody therapy?

  • Those who are hospitalized due to COVID-19
  • Those who require oxygen therapy due to COVID-19
  • Those who are on chronic oxygen therapy due to an underlying condition (not related to COVID-19) and who require an increase in baseline oxygen flow rate because of COVID-19

Who is eligible for monoclonal antibody therapy?

Monoclonal antibody therapy is available to individuals who meet the following criteria:

  • Have a positive COVID-19 test AND have not been admitted to the hospital AND
  • Have a high risk** for developing severe COVID-19 AND
  • Are 12 years of age or older (and are at least 88 pounds) AND
  • For whom alternative COVID-19 treatment options approved or authorized by FDA are not accessible of clinically appropriate

Who is eligible for pre-exposure prophylaxis therapy?

Pre-exposure prophylaxis for prevention of COVID-19 in adults and pediatric patients > 12 years of age or older (and are at least 88 pounds), this is for patients not currently infected with COVID-19 and who have not had a known recent exposure to an individual with COVID-19 and who meet the following criteria:

  • Moderate to severe immune compromise due to a medical condition of receipt of immunosuppressive medications or treatments AND
  • May not mount an adequate immune response to the COVID-19 vaccines

**High risk includes any of the following:

  • 65 years of age or older
  • Overweight (body mass index over 25)
  • Pregnancy
  • Chronic kidney disease
  • Diabetes (Type 1 and Type 2)
  • Weakened immune system
  • Currently receiving immunosuppressive treatment
  • Cardiovascular disease/hypertension
  • Chronic lung disease
  • Sickle cell disease
  • Neurodevelopmental disorders
  • Medical-related technological dependence

REMINDER: Evusheld is available through the Cancer Center Infusion Center with an approved order from a primary care provider. Order forms are available through the Cancer Center. All other therapies are available through the Cheyenne Regional Medical Emergency Department.

Note: Monoclonal Antibody Therapy is not a substitute for vaccination.